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Abstract: The actin cytoskeleton plays an important role in various cellular processes. The different forms of 
actin (G-actin and F-actin) participate in the organization of nuclear structure and its functions. The structure 
of the actin cytoskeleton is controlled by proteins involved in the translocation of actin between cytoplasm and 
the nucleus. In this study, we used siRNA method to investigate the role of exportin 6 in the switching between 
nuclear and cytoplasmic F-actin pools in H1299 cells treated with no, 1.0 or 2.5 µM doxorubicin. We showed 
that silencing of exportin 6 expression changed the response of H1299 to doxorubicin. Here, we observed incre-
ased population of cells affected by doxorubicin-induced necrotic cell death. Furthermore, fluorescence studies 
showed that downregulation of exportin 6 exerted profound DOX-induced changes in the F-actin cytoskeleton 
architecture. The F-actin cytoskeleton was seen in the form of small fibers or aggregates after doxorubicin 
treatment. Additionally, some cells lost cell adhesion properties. Downregulation of exportin 6 influenced also 
transcriptional activity of the cells. In cells transfected with nontargeting siRNA, we observed a higher level of 
5’-fluorouridine fluorescence than in cells with silenced exportin 6 expression. In conclusion, we showed that 
downregulation of exportin 6 induced necrotic cell death. Moreover, the observed alterations of cell adhesion 
suggest the key role of cytoplasmic F-actin in maintaining intercellular junctional complexes and/or focal adhesion 
properties and the importance of the balance between nuclear and cytoplasmic F-actin pools. (Folia Histochemica 
et Cytobiologica 2014, Vol. 52, No. 3, 195–205)
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Introduction
In recent years, many papers concerning the actin cy-
toskeleton have been published. It is well known that 
actin is localized in the cytoplasm and plays a key role 
in many cellular processes, such as proliferation, diffe-
rentiation, and cell death. Actin filaments also parti-
cipate in the control of cell shape, intracellular trans-
port, cell motility, exocytosis, endocytosis, and carci-
nogenesis [1–3]. The cytoplasmic localization of actin 
is important in maintaining not only cell homeostasis, 
but also its level in the cell nucleus. Nuclear actin was 
identified for the first time over 30 years ago, but its 
functional significance and form have been questio-
ned for a long time. The study presented by Dingová 
et al. showed that the nuclear actin structure is fun-
damentally different from actin structures observed 
in the cytoplasm, and pointed out that the equili-
brium between nuclear actin forms is controlled and 
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regulated by cytoplasmic actin-binding proteins [4]. 
It was also postulated that many different forms of 
actin are involved in organizing nuclear structure and 
function. It has now been established that nuclear 
actin is associated with all three RNA polymerases 
(Pol I, II, III) and is a component of many chromatin 
remodeling complexes, such as mammalian BAF com-
plex, which belongs to the family of SWI/SWF-like 
chromatin-remodeling complexes [5–7]. Percipalle 
et al. demonstrated that actin colocalized with the 
heterogeneous nuclear ribonucleoprotein hrp65-2 in 
Chironomus tentants, which was important in the tran-
scriptional activity of cells [8, 9]. Moreover, there is 
evidence that actin has also the ability to bind to hrp36 
and to participate in the process of transcription of 
Balbiani rings by RNA polymerase (RNAP II) [8, 9]. 
Furthermore, actin was localized in the nucleoli and 
it was suggested that nuclear actin cooperates with 
nuclear myosin and takes part in the transport of 
ribosomal subunits to the cytoplasm [10]. Actin was 
also found in Cajal bodies, which suggests their role 
in the transport of ribonuclear particles (RNPs) and 
small RNAs [11–13].
The mechanisms of the nucleocytoplasmic trans-
port of actin tend to be very complex on account of 
the size of actin and because of the lack of a classical 
nuclear localization signal (NLS) [14]. It has also 
been suggested that many actin-binding proteins have 
NLS, which thus makes it possible to import actin into 
the nucleus [15]. In 2003, a novel family of proteins, 
exportin 6 (XPO6), was identified. It was shown that 
exportin 6 enabled the translocation of actin to the 
cytoplasm in a functional complex with profiling [16]. 
During translocation, the actin is connected with 
exportin 6, but the profilin is needed to enhance their 
interactions [16].
Due to the previous studies that have indicated the 
significance of nuclear actin and/or nuclear F-actin in 
active cell death types, including apoptosis and mitotic 
catastrophe, we have decided here to investigate the 
effects of doxorubicin (DOX) in the adenocarcinoma 
cell line H1299 with an alternated balance between 
nuclear and cytoplasmic actin pools [2–3].
The aim of the present study was to determine the 
effects of downregulating the expression of exportin 6 
on the sensitivity of human non-small-cell lung car-
cinoma H1299 cells to the cytostatic effect of DOX. 
Material and methods
Cell culture and treatment. The H1299 cell line (human 
non-small-cell lung carcinoma cells; NSCLC) was purchased 
from the American Type Culture Collection. The cells, 
grown in Tissue Culture Flasks (25 cm2) or 12-well plates 
(BD Biosciences, Franklin Lakes, NJ, USA), were cultured 
in a monolayer in RPMI 1640 medium (Lonza, Verviers, 
Belgium) supplemented with 10% fetal bovine serum (FBS; 
Gibco/Invitrogen Life Technologies, Carlsbad, CA, USA) 
and 50 µg/mL gentamycin (Sigma-Aldrich, St. Louis, MO, 
USA) (37°C and 5% CO2). 
To induce cell death, the H1299 cells were treated with 
doxorubicin (DOX; Sigma-Aldrich) diluted in 1X DPBS 
(Dulbecco’s Phosphate-Buffered Saline; Sigma-Aldrich) 
at concentrations of 1 and 2.5 µM for 24 h. The control 
cells were grown under the same conditions but without 
the addition of DOX.
Transfection method. To transfect H1299 cells, the cells 
were grown up to 80–90% confluency in RPMI 1640 
(Lonza) with FBS (Gibco/Life Technologies) and 50 µg/mL 
gentamycin (Sigma-Aldrich). Following trypsinization, the 
suspended cells were transfected using the SE Cell Line 
4D-Nucleofector X Kit (Lonza), according to the manufac-
turer’s instructions. Briefly, 1 × 106 cells were suspended 
in 100 µl of SE nucleofector solution mixed with siRNA 
Hs_XPO6_1, predesigned to be directed against human 
XPO6 (Qiagen, Hilden, Germany). Next, the mixture of cells 
and transfection solution was transferred into transfection 
cuvettes and electroporated using a 4D-Nucleofector system 
(Lonza). To determine the nonspecific effects of siRNA 
transfection, nontargeting AllStars negative control siRNA 
(Qiagen) was used. At 72 h post transfection, the cells were 
used for further experiments. Each experiment was repeated 
independently three times.
Western blot analysis. Semiquantitative analysis of the 
posttranslational expression of exportin 6 was performed 
using the Western blot technique, according to the method 
described by Kong et al. with some modifications [17]. Brief-
ly, the cells were lysed with RIPA buffer (Sigma-Aldrich). 
Following, normalization of the protein concentration was 
performed using a BCA protein assay kit (Thermo Scientific 
Pierce, Rockford, IL, USA). Equal amounts of protein (15 µg 
of total protein per lane) were separated using 4–12% NuPage 
Bis-Tris gel (Novex/Life Technologies, Carlsbad, CA, USA) 
and transferred onto nitrocellulose membranes using the 
iBlot dry western blotting system (Invitrogen/Life Tech-
nologies). Prestained molecular weight markers (Thermo 
Scientific Pierce) were used to estimate the position of the 
protein bands. Subsequently, the membranes were processed 
using the BenchPro 4100 card processing station (Invitrogen/ 
/Life Technologies, Carlsbad, CA, USA). The membranes 
were blocked with 5% nonfat milk in TBS-T for 2 h, and then 
incubated with the primary rabbit anti-exportin 6 (1:200; 
Santa Cruz Biotechnology, Dallas, TX, USA) and rabbit 
anti-GADPH (1:5,000; Sigma-Aldrich) antibodies, diluted 
in TBS-T for 2 h at room temperature. After washing with 
TBS-T, the membranes were incubated with the secondary 
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antibodies conjugated with peroxidase (1:80,000; Sigma-Al-
drich), diluted in TBS-T for 1 h at room temperature. The 
immunoreactive bands were visualized using enhanced 
chemiluminescence (ECL) on CL-XPosure Film (Thermo 
Scientific Pierce). After scanning, the densitometry of the 
bands was quantified using Quantity One Basic software, 
v. 3.6.5 (Bio-Rad; Hercules, CA, USA).
Analysis of cell death. The analysis of cell death was carried 
out using a Tali image-based cytometer (Invitrogen/Life 
Technologies) and a Tali apoptosis kit (Invitrogen/Life 
Technologies), according to manufacturer’s instructions. 
After incubation of the cells with 1 or 2.5 µM DOX, the 
cells were trypsinized, centrifuged (300 g for 5 min), and 
resuspended in 100 µL Annexin binding buffer. After 
that, 5 µL of Annexin V Alexa Fluor 488 (Invitrogen/Life 
Technologies) was added to each sample, mixed well, and 
incubated at room temperature in the dark for 20 min. 
Next, the cells were centrifuged and resuspended again in 
100 µL of Annexin binding buffer. Then, 1 µL of propidium 
iodine (PI) was added to each sample, and samples were 
incubated at room temperature in the dark for 3 min. The 
analysis was performed using a Tali image-based cytometer 
and the FCS Express Research Edition software (v. 4.03; De 
Novo Software, Glendale, CA, USA) on the condition that 
early apoptotic cells stain only green with Annexin V, late 
apoptotic cells stains with both PI (blue) and Annexin V, 
necrotic cells stain with PI, and live cells remain unstained. 
Fluorescence microscopy. Staining of exportin 6/F-actin. 
The H1299 cells transfected with siRNAXPO6 and nontar-
geting siRNA were seeded on sterile glass coverslips placed 
in 12-well plates (BD Biosciences) and stained according 
to method described by Kinikoglu et al. (2014), with some 
modifications [18]. After 24 h, the cells were treated with 
either 1 µM or 2.5 µM DOX for additional 24 h and then 
fixed with 4% paraformaldehyde in PBS for 20 min at room 
temperature. Next, the cells were washed with PBS (3 × 5 
min), permeabilized with 0.1% Triton X-100 in PBS for 
5 min, washed again with PBA, and blocked in 1% (w/v) BSA/ 
/PBS for 1 h. Exportin 6 was stained with rabbit anti-exportin 
6 antibody (1:100; Santa Cruz Biotechnology) and then with 
anti-rabbit antibody-Alexa Fluor 555 (1:500; Invitrogen/ 
/Life Technologies). The cells were then incubated with 
phalloidin conjugated to Alexa Fluor 488 (1:40; Invitrogen/ 
/Life Technologies) for 20 min at room temperature. Nuclear 
staining was performed with 4’,6’-diamidino-2-phenylindole 
dihydrochloride (100 ng/mL; DAPI, Sigma-Aldrich) for 
10 min. All incubations were performed at room tempera-
ture. After counterstaining with DAPI, the cells were rinsed 
with PBS and mounted in Aqua-Poly/Mount (Polysciences, 
Warrington, PA, USA). The cells were examined using a C1 
laser-scanning confocal microscope (Nikon, Tokyo, Japan). 
5 FUrd/F-actin staining. After the DOX treatment, the 
H1299 cells were incubated in complete medium contain-
ing 5’-fluorouridine (FUrd) (Sigma-Aldrich), for 20 min at 
37°C in 5% CO2, fixed with 4% paraformaldehyde in PBS 
for 20 min at room temperature and permeabilized with 
0.1% Triton X-100 in PBS for 5 min. The cells were then 
blocked with 1% BSA and stained with mouse anti-BrdU 
(1:250; Sigma-Aldrich) in PBS to visualize the incorporat-
ed FUrd. After 1 h incubation with the primary antibody, 
the cells were washed with PBS and stained for 1 h using 
anti-mouse secondary antibody conjugated to Alexa Fluor 
488 (Invitrogen/Life Technologies). Next, the cells were 
washed and incubated with phalloidin conjugated to TRITC 
(Sigma-Aldrich) for 20 min. Nuclear staining was performed 
with DAPI (100 ng/mL; Sigma-Aldrich) for 10 min. All 
incubations were performed at room temperature. After 
counterstaining, the cells were rinsed with PBS and mounted 
in Aqua-Poly/Mount (Polysciences). The cells were exam-
ined using a classical fluorescence and C1 laser-scanning 
confocal microscopes (Nikon, Tokyo, Japan).
Statistical analysis. The statistical analyses were perfor-
med with the Mann-Whitney U-test using GraphPad Prism 
software (Ver5.0; GraphPad software). The results were 
considered significant at p ≤ 0.05.
Results
Downregulation of exportin 6 by the siRNA
The downregulation of exportin 6 expression with 
siRNA Hs_XPO6_1, predesigned to be directed against 
human XPO6, was examined by using the Western 
blotting method. The densitometric analysis indicated 
a significant reduction in the posttranslational expres-
sion of exportin 6 in the siRNA-transfected control 
cells exposed to 1 and 2.5 µM DOX (Figure 1). After 
Figure 1. Silencing of exportin 6 expression. H1299 cells 
were transfected with nontargeting AllStars negative con-
trol siRNA and siRNA Hs_XPO6_1 predesigned against 
human XPO6, exposed to 0, 1.0 and 2.5 µM DOX. After 
treatment, exportin 6 proteins were analyzed by Western 
blot. After transfection of H1299 cells with siRNA, the 
silencing of exportin 6 expression was 64.36%, 89.80%, and 
94.28%, compared to control and 1 or 2.5 µM DOX-treated 
cells, respectively. Abbreviations: CTRL — control cells; 
DOX — doxorubicin-treated cells
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the transfection of the H1299 cells with siRNA, the 
level of exportin 6 was 64.36%, 89.80%, and 94.28% 
compared to control cells transfected with nontar-
geting siRNA and treated with DOX at doses 1 and 
2.5 µM, respectively (Figure 1).
Downregulation of exportin 6 promotes  
DOX-induced necrosis
Cell death analysis was performed using a Tali ima-
ge-based cytometer and Tali apoptosis kit, consisting 
of Annexin V-Alexa Fluor 488 and propidium iodide 
to identify cells undergoing apoptotic and necrotic 
cell death. 
In the cells transfected with nontargeting siRNA 
and siRNAXPO6, statistically significant differences in 
the percentage of live cells were observed following 
treatment with all doses of DOX, as compared to the 
appropriate control cells. The percentage of live cells 
transfected with nontargeting siRNA and treated with 
1 and 2.5 µM DOX was slightly decreased from 93.4% to 
90.7% (p = 0.04) and 87.8% (p = 0.04), respectively, in 
comparison to the untreated control cells (Figure 2A). 
Statistically significant differences in the percentage 
of live cells were noticed in siRNAXPO6-transfected 
cells. The percentage of live control cells was 85.5%, 
however, after treatment of the cells with 1 and 2.5 µM 
DOX, it decreased to 78.2% (p = 0.0361) and 56.2% 
(p = 0.0361), respectively (Figure 2A). Statistically 
significant differences in the percentage of live cells 
between cells transfected with nontargeting siRNA and 
siRNAXPO6 were also noticed (Figure 2A). 
Moreover, we observed a small population of early 
apoptotic cells, stained only with Annexin V and of 
Figure 2. Effect of DOX on the induction of cell death. H1299 transfected with the siRNA negative control and siRNA 
Hs_XPO6_1 were treated with 0, 1.0 and 2.5 µM doxorubicin for 24 h and double-stained with Annexin V Alexa Fluor 
488 and propidium iodide. Analysis was performed using an image-based cytometer as described in Methods. A. Percent-
age of live cells in H1299 cells transfected with siRNA negative control and siRNAXPO6; B. Percentage of early apoptotic 
cells; C. Percentage of late apoptotic cells; D. Percentage of necrotic cells. *Statistically significant differences between 
control cells and cells treated with doxorubicin; p < 0.05; Mann-Whitney U-test. **Statistically significant differences be-
tween cells transfected with siRNA negative control or siRNA knockdown of exportin 6; p < 0.05; Mann-Whitney U-test
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late apoptotic cells, stained with propidium iodide and 
Annexin V. In the H1299 cells transfected with non-
-targeting siRNA, a statistically significant decrease, 
from 1.03% to 0.26% and 0.48%, in the percentage of 
early apoptotic cells was observed following treatment 
with 1 and 2.5 µM DOX, respectively (Figure 2B). 
However, in the population of siRNAXPO6-transfec-
ted cells, statistically significant differences were not 
noticed. However, statistically significant decreases 
between cells transfected with nontargeting siRNA 
and siRNAXPO6 were observed (Figure 2B). The 
analysis of the DOX-induced late apoptosis in cells 
transfected with nontargeting siRNA showed a stati-
stically significant increase in the percentage of cells, 
from 0.70% to 0.88%, following treatment with 1 µM 
DOX. In the case of siRNAXPO6-transfected cells, the 
statistically significant differences were observed only 
after treatment of cells with 1 µM DOX (Figure 2C). 
As shown in Figure 2D, the population of necrotic 
cells following transfection with nontargeting siRNA 
and treatment with DOX was statistically significant 
increased from 4.23% to 7.85%, and 10.29% in the 
control and after treatment with doses of 1 and 2.5 µM 
DOX, respectively. Moreover in siRNAXPO6-transfec-
ted cells, the differences between the control and the 
cells treated with DOX were highly significant: 13.7% 
of control cells were necrotic, and this value increased 
to 29.7% (p < 0.0001) and 39.5% (p < 0.0001) after 
treatment with 1 and 2.5 µM DOX, respectively. 
Moreover, statistically significant differences between 
the cells transfected with nontargeting siRNA and 
siRNAXPO6 were also noticed. 
Downregulation of exportin 6 expression disrupts 
F-actin cytoskeleton and reduces cell adhesion
The morphology of the control cells transfected with 
nontargeting siRNA was not changed as compared 
to non-transfected cells: they adhered to each other, 
had a polyhedral shape, and contained one oval or 
kidney-shaped nucleus. In these cells, a voluminous 
network of actin cytoskeleton and bundles of tension 
fibers were observed. We also noticed short fibers of 
actin filaments in the perinuclear area and high in-
tensity of cortical F-actin fluorescence in the cell–cell 
interaction areas (Figure 3A and A’). Exportin 
6 was located in the cell nuclei (Figure 3A and A’). 
Following treatment with DOX, the architecture 
of the actin cytoskeleton was changed. The dose of 
1 µM DOX induced a significantly lower number of 
stress fibers. F-actin appeared in the form of short 
fibers in the cytoplasm and in the perinuclear area. 
Nevertheless, contact between cells and the intense 
F-actin fluorescence in the cell–cell interactions were 
observed. Additionally, giant cells with multiple nuclei 
of different sizes were seen. In cells exposed to the 
1 µM dose of DOX, a higher intensity of exportin 6 in 
the nucleus was seen than in the control (Figure 3B 
and B’). The degradation of the F-actin cytoskeleton 
was observed following treatment of cells with 2.5 µM 
DOX. Furthermore, the short fibers of the actin 
filaments in the cytoplasm, F-actin, aggregated 
in the perinuclear region, and the highest intensity 
of exportin 6 fluorescence was also seen there 
(Figure 3C and C’). 
The transfection of cells with siRNAXPO6 induced 
profound changes in the F-actin cytoskeleton. We ob-
served a few cells on the slides that lost cell adhesion 
properties (Figure 4A’–C’). In the control cells, which 
were not incubated with DOX, thick stress fibers of 
F-actin were observed (Figure 4A). After treating the 
cells with 1 µM DOX, the F-actin cytoskeleton was 
destroyed and only small fibers or F-actin aggregates 
were observed (Figure 4B). Similarly, the destruction 
of the actin cytoskeleton was seen following treatment 
with 2.5 µM DOX (Figure 4C). However, the number 
of small fibers or F-actin aggregates was greater than 
in cells treated with 1 µM DOX.
Additionally, in cells transfected with nontargeting 
siRNA, we observed a gradual increase in the fluore-
scence of the F-actin in the nuclear area following 
DOX treatment (Figure 3A–C’). Nuclear F-actin 
was also seen in siRNAXPO6-transfected cells in the 
control and in cells treated with DOX (Figure 4A–C’). 
However, the nuclear F-actin accumulation was more 
evident and associated with weaker DNA staining.
Downregulation of exportin 6 induces changes  
in the transcriptional activity of the H1299 cells
The transcriptional activity of cells was assessed 
using a 5-ﬂuorouridine (FUrd) incorporation assay. 
In cells transfected with nontargeting siRNA, we 
observed a higher level of 5-FUrd fluorescence than 
in the siRNAXPO6-transfected cells (Figures 5A–C 
and 6A–C). All the nuclei of the controls transfected 
with nontargeting siRNA were characterized by very 
intense fluorescence of 5-FUrd, but after treatment 
with DOX, this signal gradually decreased. We also 
noticed that in morphologically altered nuclei, the 
intensity of the 5-FUrd was lower (Figure 5A–C). 
In the control of siRNAXPO6-transfected cells, the 
intensity of the 5-FUrd was very high, but foci-like 
signals were seen (Figure 6A). The similar results 
were seen in cells with multiple nuclei following 
treatment with 1 µM DOX (Figure 6B). By contrast, 
in 2.5 µM DOX treated cells, the identification of 
5-FUrd was not possible (Figure 6C). The structure 
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of the actin cytoskeleton was identical to that descri-
bed above (Figures 5A’–C’ and 6A’–C’). Moreover, 
in both negative controls and in the cells transfected 
with siRNAXPO6, weaker DNA staining was observed 
following DOX treatment.
Discussion
Changes in nuclear actin levels have been linked to 
various cellular processes, because actin may function 
as a switch between transcriptional states. Actin has 
neither a classic nuclear localization signal (NLS) nor 
a specific import receptor, so the transport of this 
protein is hampered. However, many actin-binding 
proteins contain a nuclear localization sequence and 
can thus be responsible for the translocation of actin 
into the nucleus [15].
It is known that cofilin is one such protein media-
ting the active transport of actin into nucleus under 
physiological conditions; as an actin-binding protein 
(ABP), it plays a role in the regulation of actin dyna-
mics [19]. We previously reported that downregula-
tion of cofilin influenced changes in the localization 
pool of F-actin in CHOAA8, and as a consequence, 
Figure 3. Localization of exportin 6 and F-actin in control and DOX-treated H1299 cells. H1299 cells were treated with 
0, 1.0 and 2.5 µM DOX and labeled for the presence of exportin 6 (red) and F-actin (green) as described in Methods. 
Cell nuclei were labeled with DAPI. A–A’. Control cells: very low nuclear fluorescence signal of exportin 6 and typical for 
H1299 cells architecture of F-actin cytoskeleton; B–B’. 1 µM DOX: nuclear fluorescence of exportin 6 and F-actin in the 
form of short fibers in the cytoplasm and in the perinuclear area; C–C’. 2.5 µM DOX: high nuclear fluorescence signal of 
exportin 6 and degradation of the F-actin cytoskeleton. Abbreviations as for Figure 1. Bar, 50 µm
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no apoptotic cell death was observed following tre-
atment with DOX [20–21]. These results were very 
interesting, because they presented the important role 
of nuclear F-actin in cell-death induction processes. 
Therefore, in this study we have examined the effect of 
downregulating the expression of exportin 6, another 
important protein in the translocation of F-actin 
between the cell nucleus and the cytoplasm, in the 
context of the reorganization of the actin cytoskeleton 
and also of the sensitivity of human non-small-cell 
lung carcinoma cells (H1299 cell line) to DOX which 
is a well-known cytostatic drug. 
We observed changes in the organization of actin 
filaments and the various fluorescent intensities of 
exportin 6 in cells transfected with siRNAXPO6. The re-
sults also showed that silencing of exportin 6 changed 
not only form and distribution of actin cytoskeleton 
but also the adhesion properties of cells. At both 
applied DOX concentrations, there was a significant 
reduction in the number of stress fibers, similarly 
to the findings of Pawlik et al. on H1299 cells after 
treatment with phenethyl isothiocyanate [22]. We 
also observed the presence of F-actin in the nucleus 
and its higher fluorescence after DOX treatment. 
Figure 4. Localization of exportin 6 and F-actin in control and DOX-treated H1299 cells with silenced XPO6 expression. 
H1299 cells transfected with siRNAXPO6 were treated with 0, 1.0 and 2.5 µM DOX and labeled for the presence of expor-
tin 6 (red) and F-actin (green) as described in Methods. Cell nuclei were labeled with DAPI. A–A’. Control cells: lack of 
exportin 6 fluorescence signal and perturbation of F-actin cytoskeleton architecture; B–B’. 1 µM DOX: lack of exportin 6 
fluorescence signal and destruction of F-actin; C–C’. 2.5 µM DOX: lack of exportin 6 fluorescence signal and destruction 
of F-actin. Abbreviations as for Figure 1. Bar, 50 µm
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However, it has been shown here that the DNA sta-
ining and transcriptionally active regions in the cell 
nucleus were reduced. On the other hand, Johnson 
et al. (2013) observed the enhancement of the nuc-
lear localization of actin when cells were exposed to 
stress conditions, and suggested that nuclear F-actin 
is involved in structural changes of chromatin during 
cell death or the transcription of genes significant 
for cell death induction [23]. However, the normal 
H1299 cells are resistant to DOX due to the lack of 
functional expression of p53 [24] so that cell death was 
thus not observed after treatment with this cytostatic 
drug [25]. However, after the H1299 cells transfected 
with siRNAXPO6 were treated with DOX, we observed 
the induction of cell death. 
It is known that the mechanism of DOX action is 
highly dose-dependent. Many studies using different 
cell lines showed that low concentrations of DOX 
promote cell senescence or mitotic catastrophe, 
while higher doses induce apoptosis [26–29]. In the 
present study, H1299 cells showed cell shape changes 
following DOX treatment. In siRNA-negative control 
transfected cells which had been treated with DOX, 
we observed a few giant cells with lobulated nuclei 
or multiple nuclei, characteristic of mitotic catastro-
phe. The mechanism of this type of cell death is not 
clear, but the described process is usually combined 
with abnormal mitosis and multinucleated giant cells 
[30–32]. Results similar to those of the present paper 
were presented by Pawlik et al. on hyperthermia tre-
Figure 5. Effect of DOX on transcriptional activity of the H1299 cells. H1299 cells were treated with 0, 1.0 and 2.5 µM 
doxorubicin and labeled for the presence of 5-FUrd (green) and F-actin (red) as described in Methods. Cell nuclei were 
labeled with DAPI. A–A’. Control cells; B–B’. 1 µM DOX; C–C’. 2.5 µM DOX. Abbreviations as for Figure 1 and 5-FUrd 
— 5’-fluorouridine. Bar, 50 µm
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atment of H1299 cells [22], Zhang et al. on exposure 
of human lung cancer cells to 8-chloro-adenosine [33], 
and Li et al. using the adenovirus E4orf4 protein [34]. 
These reports all indicated that mitotic catastrophe 
frequently occurred in H1299 cells cultured under 
stress conditions [33–35]. Our image-based cytometry 
analysis of Annexin V/propidium iodide double-
-stained H1299 cells showed the externalization of 
phosphatidylserine in the plasma membrane, which 
is typical of apoptosis, but these populations of cells 
transfected with nontargeting siRNA and siRNAXPO6 
were very small. However, in this study, a dose-de-
pendent increase and PI-double positive cells were 
observed. This is in agreement with the study of Ulu-
kaya et al. who showed that various compounds (such 
as platinum and palladium complexes) did not induce 
apoptosis, but rather necrosis [36]. Similar results 
were presented by Li et al. who found that adenovirus 
E4orf4 protein-induced membrane blebbing resulted 
in the formation of multiple nuclei and increased 
cell volume, which are typical for necrosis [35]. We 
suggest here that this type of cell death is associated 
with the H1299 cell line treated with DOX. It has also 
been pointed out that mitotic catastrophe is induced 
in cells that lack functional p53 [37]. By contrast, as 
in the case of the H1299 cell line, Tang et al. have 
associated this mutation with necrosis, suggesting 
a novel link between p53 and inflammatory proces-
Figure 6. Effect of DOX on transcriptional activity of the H1299 cells with silenced XPO6 expression. H1299 cells trans-
fected with siRNAXPO6 were treated with 0, 1.0 and 2.5 µM doxorubicin and labeled for the presence of 5-FUrd (green) 
and F-actin (red) as described in Methods. Cell nuclei were labeled with DAPI. A–A’. Control cells; B–B’. 1 µM DOX; 
C–C’. 2.5 µM DOX. Abbreviations as for Figure 5. Bar, 50 µm
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ses [38]. However, in the present study, evidence for 
DOX-induced necrosis was noticed. 
Our another major observation involved the alte-
rations of cell shapes associated with the reorganiza-
tion of the F-actin cytoskeleton. The actin maintains 
the cell’s shape and participates in regular cellular 
motility [39]. These processes are highly dependent 
on the rearrangements of the F-actin cytoskeleton and 
the balance between cytoplasmic and nuclear actin 
pools. Dopie et al. confirmed that actin is constantly 
exported out of the nucleus and that this process is 
mediated by exportin 6, independently of Crm1 [40]. 
This contradicts the data presented by Stüven et al. 
that Crm1 plays important role in actin transport from 
mammalian or insect nuclei [16]. In our study, we used 
siRNA technique to downregulate the expression of 
exportin 6, and similarly to Bohnsack et al. [41] we 
showed an accumulation of actin in the nucleus after 
transfection with siRNAXPO6. Moreover, we observed 
that only a few cells remained on the slides following 
the transfection of the H1299 cells with siRNAXPO6, 
which suggest that this may be connected with altered 
translocation of actin between cytoplasm and cell 
nucleus. This assumption is confirmed by our previous 
study, which demonstrated that the stabilization of the 
cytoplasmic pool of F-actin by the overexpression of 
tropomyosin-1 strengthens cellular junctions through 
the preservation of F-actin’s polymerization state, and 
then protects endothelial cells against stress agents 
(such as L-homocysteine) [42]. 
Nuclear actin is a key regulator of polymera-
se II-dependent transcription and is required for 
RNA polymerase I transcription [43–44]. Zhang et 
al. showed the localization of FUrd in the nucleoli 
and connected this with active RNA polymerase I 
transcription [45]. On the other hand, Obrdlik and 
Percipalle observed the same localization of 5-FUrd 
as in the present study, and related this staining with 
polymerase II RNA. They also showed that cofilin-1 
was involved in the machinery of transcription of 
certain genes, in which interaction with actin was 
involved [46]. Additionally, they suggested that the 
controlled polymerization of actin may be important 
for polymerase II transcription. In the present study, 
in the control of siRNAXOP6-transfected cells and in 
cells with multiple nuclei following treatment with 
1 µM DOX we noticed foci-like structures of 5-FUrd 
indicative of transcriptional activity. In contrast, in 
cells treated with 2.5 µM DOX, the identification 
of 5-FUrd was not possible, what suggest the lack of 
transcription. In a similar way, Obrdlik and Percipalle 
showed very low levels of FUrd foci fluorescence after 
the silencing of the cofilin-1 gene [46]. They associated 
these changes with the strict relationship between the 
involvement of cofilin-1 in polymerase II transcription 
elongation and the polymerization of gene-associated 
actin. It is also very interesting that the low level of 
cofilin-1 expression was related to the increase in 
the nuclear F-actin pool, meaning that the silencing 
of the cofilin-1 gene induced the polymerization of 
actin and promoted the formation of atypical F-actin 
structures in the nucleus area [46]. All the studies 
presented above show the different ways in which 
actin contributes in the transcription machinery. Our 
study provides further clues to the actin involvement 
in many processes inside the nucleus and suggests 
that exportin 6 alters the balance between nuclear 
and cytoplasmic pools of F-actin via the induction of 
different cell-death modes.
In conclusion, we showed that after downregula-
tion of exportin 6 expression in H1299 cells, doxo-
rubicin induced necrotic cell death. Also important 
was the observation of cell adhesion alterations, 
which support the key role of cytoplasmic F-actin in 
cell adhesion and the importance of maintaining of 
nuclear and cytoplasmic pools of F-actin. 
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